Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(OP:PMXSF)

N/A UNCHANGED
Last Price Updated: 2:13 PM EST, Mar 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PMXSF

Pharmaxis to focus on clinical-stage drug development
--News Direct-- 
Via News Direct
Pharmaxis to focus on clinical-stage drug development
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company is set to undergo a restructure to refocus on developing drugs to treat blood-related cancers. This involves the... 
Via TheNewswire.com
Pharmaxis says majority of patients in fibrosis trial see significant improvement
Pharmaxis says majority of patients in fibrosis trial see significant improvement 
Via News Direct
Pharmaxis says majority of patients in fibrosis trial see significant improvement
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips speaks with Proactive after releasing data from a final interim analysis of 10 patients who have completed six months’ treatment with its drug... 
Via TheNewswire.com
Pharmaxis extends scarring collaboration after encouraging results
Pharmaxis extends scarring collaboration after encouraging results 
Via News Direct
Pharmaxis extends scarring collaboration after encouraging results
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company has made great progress towards commercialisation in a Phase 1C study of its topical Pan LOX inhibitor, achieving a... 
Via TheNewswire.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.